Novel inhibitors of the high-affinity l-proline transporter as potential therapeutic agents for the treatment of cognitive disorders
Authors:
- 1 August 2014
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 24 (16) , 3886-3890
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Developing and validating trace fear conditioning protocols in C57BL/6 miceJournal of Neuroscience Methods, 2014
- Discovery and characterization of potent small molecule inhibitors of the high affinity proline transporterNeuroscience Letters, 2009
- Forecasting the global burden of Alzheimer's diseaseAlzheimer's & Dementia, 2007
- Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guidelineEuropean Journal of Neurology, 2007
- Trace Conditioning and the Hippocampus: The Importance of ContiguityThe Journal of Neuroscience, 2006
- A Role for Prefrontal Cortex in Memory Storage for Trace Fear ConditioningJournal of Neuroscience, 2004
- GalantamineDrugs, 2000
- Localization of the Brain-Specific High-Affinityl-Proline Transporter in Cultured Hippocampal Neurons: Molecular Heterogeneity of Synaptic TerminalsMolecular and Cellular Neuroscience, 1999
- Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?European Journal of Pharmacology, 1998
- Mammalian Brain-specific L-Proline Transporter.Journal of Biological Chemistry, 1995